Biosimulation Leader SLP Pushes Back Q3 Results Amid Filer Status Change

Rhea-AI Filing Summary

Simulations Plus (SLP), a provider of cheminformatics and biosimulation solutions for the biopharma industry, announced a rescheduling of its Q3 FY2025 financial results release and conference call. The company has delayed these events from the original date of July 2, 2025, to the following schedule:

• Conference call: July 14, 2025, at 5:00 p.m. Eastern Time
• Financial results release: July 15, 2025, before market open

The delay utilizes the maximum time allowed under regulations following the company's status change from a large accelerated filer to a non-accelerated filer. This material event was reported via Form 8-K and includes a press release (Exhibit 99.1) containing the rescheduling details. The filing indicates a notable change in the company's filing status and timing of financial disclosures, which could be significant for investors tracking reporting obligations and corporate governance.

Positive

• None.

Negative

• Company delayed Q3 2025 earnings release to the last possible filing date (July 15) after transitioning from large accelerated filer to non-accelerated filer status, potentially indicating reporting complexities or challenges
• Downgrade in filer status from large accelerated to non-accelerated filer suggests decreased market capitalization or public float, which could impact trading liquidity

Insights

Corporate Communications Analyst

SLP delays Q3 results to filing deadline after downgrading from large accelerated filer status—often a concerning signal.

This filing reveals a concerning development as Simulations Plus has delayed its Q3 financial results announcement to July 15, 2025—the absolute last day permitted by regulations—rather than the originally scheduled July 2 date. More importantly, the company discloses it has transitioned from a large accelerated filer to a non-accelerated filer status. This downgrade in filing status typically occurs when a company's public float falls below $700 million—a significant market capitalization reduction. The explicit mention that they're "using all of the time allowed by regulation" following this status change raises red flags. In corporate communications, such delays often precede disappointing results or indicate accounting complexities requiring additional scrutiny. While the company provides no explanation for the delay beyond the filing status change, the decision to push to the regulatory deadline rather than simply announcing a short postponement suggests potential challenges in finalizing their financial statements. The combination of reduced market capitalization triggering the filer status change and the maximum delay in reporting warrants investor attention, as it diverges from the company's typical reporting patterns.

0001023459false00010234592025-06-182025-06-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

June 18, 2025

(Date of the earliest event reported)

Simulations Plus, Inc.

(Exact name of registrant as specified in its charter)

California			001-32046			95-4595609
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

800 Park Offices Drive, Suite 401, Research Triangle Park, NC 27709

(Address of principal executive offices) (Zip Code)

661-723-7723

Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14z-12 under Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.001 per share			SLP			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01    Other Events

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry announced that it has rescheduled the release of its financial results and conference call related to the third quarter ended May 31, 2025, which had previously been scheduled for July 2, 2025. The Company now expects to hold its conference call on Monday, July 14, 2025 at 5:00 p.m. Eastern Time and to issue its third quarter financial results before market open on Tuesday, July 15, 2025, the filing deadline. The Company is using all of the time allowed by regulation since transitioning from a large accelerated filer to a non-accelerated filer before releasing financial results and holding the conference call.

On June 18, 2025 the Company issued a press release to reschedule its third quarter ended May 31, 2025 conference call. A copy of such press release is attached hereto as Exhibit 99.1. The information contained in this Item 8.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01    Financial Statements and Exhibits

(d)    Exhibits

Exhibit Number			Description
99.1			Press Release - June 18, 2025
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			SIMULATIONS PLUS, INC.
Dated: June 18, 2025			By: /s/ Will Frederick
			Will Frederick
			Executive Vice President and Chief Financial Officer

2

FAQ

Why did SLP reschedule its Q3 2025 earnings release and conference call?

SLP rescheduled its Q3 2025 earnings release and conference call due to transitioning from a large accelerated filer to a non-accelerated filer. The company is utilizing the full time allowed by regulation before releasing financial results. The earnings will now be released before market open on July 15, 2025, with the conference call scheduled for July 14, 2025 at 5:00 p.m. Eastern Time.

When is SLP's new Q3 2025 earnings release date?

SLP will release its third quarter financial results (for the period ended May 31, 2025) before market open on Tuesday, July 15, 2025. This is a change from the previously scheduled date of July 2, 2025.

What time is SLP's rescheduled Q3 2025 earnings conference call?

SLP's rescheduled third quarter earnings conference call will be held on Monday, July 14, 2025 at 5:00 p.m. Eastern Time.

Has SLP's filing status changed with the SEC?

Yes, SLP has transitioned from being a large accelerated filer to becoming a non-accelerated filer, which affects their filing deadlines and reporting requirements.

What is the period covered by SLP's upcoming earnings report?

The earnings report will cover SLP's third quarter, which ended May 31, 2025.